Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS
Titel:
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS
Auteur:
Huls, Gerwin Chitu, Dana A. Pabst, Thomas Klein, Saskia K. Stussi, Georg Griskevicius, Laimonas Valk, Peter J.M. Cloos, Jacqueline van de Loosdrecht, Arjan A. Breems, Dimitri van Lammeren-Venema, Danielle van Zeventer, Isabelle Boersma, Rinske Jongen-Lavrencic, Mojca Fehr, Martin Hoogendoorn, Mels Manz, Markus G. Söhne, Maaike van Marwijk Kooy, Rien Deeren, Dries van der Poel, Marjolein W.M. Legdeur, Marie Cecile Tick, Lidwine Chalandon, Yves Ammatuna, Emanuele Blum, Sabine Löwenberg, Bob Ossenkoppele, Gert J.